134 related articles for article (PubMed ID: 31823876)
1. A human translational model based on neuroplasticity for pharmacological agents potentially effective in Treatment-Resistant Depression: focus on dopaminergic system.
Collo G; Merlo Pich E
Neural Regen Res; 2020 Jun; 15(6):1027-1029. PubMed ID: 31823876
[No Abstract] [Full Text] [Related]
2. Transcranial direct current stimulation and neuroplasticity genes: implications for psychiatric disorders.
Chhabra H; Shivakumar V; Agarwal SM; Bose A; Venugopal D; Rajasekaran A; Subbanna M; Kalmady SV; Narayanaswamy JC; Debnath M; Venkatasubramanian G
Acta Neuropsychiatr; 2016 Feb; 28(1):1-10. PubMed ID: 25877668
[TBL] [Abstract][Full Text] [Related]
3. Leveraging Neuroplasticity to Enhance Adaptive Learning: The Potential for Synergistic Somatic-Behavioral Treatment Combinations to Improve Clinical Outcomes in Depression.
Wilkinson ST; Holtzheimer PE; Gao S; Kirwin DS; Price RB
Biol Psychiatry; 2019 Mar; 85(6):454-465. PubMed ID: 30528745
[TBL] [Abstract][Full Text] [Related]
4. From restoration of neuroplasticity to the treatment of depression: clinical experience.
Costa e Silva JA
Eur Neuropsychopharmacol; 2004 Dec; 14 Suppl 5():S511-21. PubMed ID: 15550350
[TBL] [Abstract][Full Text] [Related]
5. Increase in PAS-induced neuroplasticity after a treatment course of transcranial direct current stimulation for depression.
Player MJ; Taylor JL; Weickert CS; Alonzo A; Sachdev PS; Martin D; Mitchell PB; Loo CK
J Affect Disord; 2014; 167():140-7. PubMed ID: 24968188
[TBL] [Abstract][Full Text] [Related]
6. Intrinsic exercise capacity in rats influences dopamine neuroplasticity induced by physical training.
Rabelo PCR; Horta NAC; Cordeiro LMS; Poletini MO; Coimbra CC; Szawka RE; Soares DD
J Appl Physiol (1985); 2017 Dec; 123(6):1721-1729. PubMed ID: 28883047
[TBL] [Abstract][Full Text] [Related]
7. Increased neuroplasticity may protect against cardiovascular disease.
Zheng Z; Zeng Y; Wu J
Int J Neurosci; 2013 Sep; 123(9):599-608. PubMed ID: 23510138
[TBL] [Abstract][Full Text] [Related]
8. Dynamics of the dopaminergic system as a key component to the understanding of depression.
Yadid G; Friedman A
Prog Brain Res; 2008; 172():265-86. PubMed ID: 18772037
[TBL] [Abstract][Full Text] [Related]
9. [Depression and treatment. Apoptosis, neuroplasticity and antidepressants].
Arantes-Gonçalves F; Coelho R
Acta Med Port; 2006; 19(1):9-20. PubMed ID: 16987439
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic modulation of long-lasting direct current-induced cortical excitability changes in the human motor cortex.
Nitsche MA; Lampe C; Antal A; Liebetanz D; Lang N; Tergau F; Paulus W
Eur J Neurosci; 2006 Mar; 23(6):1651-7. PubMed ID: 16553629
[TBL] [Abstract][Full Text] [Related]
11. Rodent models of treatment-resistant depression.
Caldarone BJ; Zachariou V; King SL
Eur J Pharmacol; 2015 Apr; 753():51-65. PubMed ID: 25460020
[TBL] [Abstract][Full Text] [Related]
12. Irritable bowel syndrome may be induced by decreased neuroplasticity.
Zheng Z; Zeng Y; Yang W; Wu J
Neuro Endocrinol Lett; 2014; 35(8):655-65. PubMed ID: 25702292
[TBL] [Abstract][Full Text] [Related]
13. Yoga- and meditation-based lifestyle intervention increases neuroplasticity and reduces severity of major depressive disorder: A randomized controlled trial.
Tolahunase MR; Sagar R; Faiq M; Dada R
Restor Neurol Neurosci; 2018; 36(3):423-442. PubMed ID: 29614706
[TBL] [Abstract][Full Text] [Related]
14. Translational approaches in treatment-resistant depression based on animal model.
Marinescu I; Vasiliu O; Vasile D
Rom J Morphol Embryol; 2018; 59(3):955-964. PubMed ID: 30534840
[TBL] [Abstract][Full Text] [Related]
15. Translational studies exploring neuroplasticity associated with motor skill learning and the regulatory role of the dopamine system.
Diaz Heijtz R; Forssberg H
Dev Med Child Neurol; 2015 Apr; 57 Suppl 2():10-4. PubMed ID: 25690110
[TBL] [Abstract][Full Text] [Related]
16. Structural Plasticity Induced by Ketamine in Human Dopaminergic Neurons as Mechanism Relevant for Treatment-Resistant Depression.
Collo G; Cavalleri L; Merlo Pich E
Chronic Stress (Thousand Oaks); 2019; 3():2470547019842545. PubMed ID: 32440593
[TBL] [Abstract][Full Text] [Related]
17. Tianeptine: a novel atypical antidepressant that may provide new insights into the biomolecular basis of depression.
Brink CB; Harvey BH; Brand L
Recent Pat CNS Drug Discov; 2006 Jan; 1(1):29-41. PubMed ID: 18221189
[TBL] [Abstract][Full Text] [Related]
18. New strategies in the development of antidepressants: towards the modulation of neuroplasticity pathways.
Vidal R; Pilar-Cuéllar F; dos Anjos S; Linge R; Treceño B; Vargas VI; Rodriguez-Gaztelumendi A; Mostany R; Castro E; Diaz A; Valdizán EM; Pazos A
Curr Pharm Des; 2011; 17(5):521-33. PubMed ID: 21375480
[TBL] [Abstract][Full Text] [Related]
19. Magnetic seizure therapy reduces suicidal ideation and produces neuroplasticity in treatment-resistant depression.
Sun Y; Blumberger DM; Mulsant BH; Rajji TK; Fitzgerald PB; Barr MS; Downar J; Wong W; Farzan F; Daskalakis ZJ
Transl Psychiatry; 2018 Nov; 8(1):253. PubMed ID: 30470735
[TBL] [Abstract][Full Text] [Related]
20. Treating comorbid anxiety and depression: Psychosocial and pharmacological approaches.
Coplan JD; Aaronson CJ; Panthangi V; Kim Y
World J Psychiatry; 2015 Dec; 5(4):366-78. PubMed ID: 26740928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
